News | CT Angiography (CTA) | June 25, 2018

Post-Mortem CT Angiography Illuminates Causes of Death

PMCTA detects 90 percent of incidental findings in examination of 500 bodies, while autopsy only finds 61 percent

Post-Mortem CT Angiography Illuminates Causes of Death

June 25, 2018 — Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-mortem diagnosis, according to a study appearing online in the journal Radiology. Researchers said the findings could have important implications for criminal investigations and hospital quality control efforts.

High-quality post-mortem investigations are vital for a number of reasons; most notably, as evidence in criminal investigations for which the body represents the main proof of a crime; and as a quality control measure for surgical interventions and medical treatment at hospitals.

Modern imaging techniques like CT and magnetic resonance imaging (MRI) are often used in forensic pathology. However, post-mortem CT is limited by relatively low soft tissue contrast and poor visualization of the vascular system. A technique known as post-mortem CT angiography (PMCTA) was developed to address those limitations by introducing contrast agent into the body.

“The idea of the PMCTA is to simulate a post-mortem circulation by establishing a post-mortem perfusion of the vascular system,” said study lead author Silke Grabherr, M.D., Ph.D., from the University Center of Legal Medicine Lausanne-Geneva in Lausanne, Switzerland. “Therefore, the heart is ‘replaced’ by a perfusion device, similar to the heart-lung machine that replaces the heart during heart surgery.”

To assess the performance of PMCTA, Grabherr and colleagues at nine centers in Europe performed conventional autopsies on 500 human bodies that had undergone PMCTA. All CT images were read by an experienced team, including one forensic pathologist and one radiologist who were blinded to the autopsy findings.

Autopsy was performed on the day of the PMCTA, or the following day, in all cases. After examination of 500 bodies, a total of 18,654 findings were recorded.

PMCTA performed surprisingly well compared to conventional autopsy. Out of 18,654 total findings, PMCTA found 90 percent, compared with 61 percent for autopsies. PMCTA missed only 10 percent of forensically essential findings, while autopsy missed 23 percent.

“This method could — in many cases — be an alternative to invasive autopsy if such an opening of the body is not possible,” Grabherr said. “This offers new investigation possibilities, for example, in countries where a conventional autopsy is not accepted or in cases where family members can refuse it.”

PMCTA was significantly superior to autopsy at identifying skeletal and vascular lesions, or areas of damage in the bones and blood vessels. PMCTA identified 96 percent of skeletal lesions and 94 percent of vascular lesions, compared with 65 percent for autopsy. These lesions can provide important information in post-mortem examinations, Grabherr said.

“The combination of bone lesions and vascular lesions is especially seen in cases of traumatic death, such as falls from height, traffic accidents, ballistic trauma, and sharp trauma in homicides and suicides,” she said. “This means that PMCTA is an excellent choice to investigate such cases and can be used combined with or even independently of conventional autopsy for investigating in these cases.”

In the future, the research group plans to study the combination of post-mortem angiography with MRI in order to increase the sensitivity of findings related to organs like the brain and liver.

For more information: www.pubs.rsna.org/journal/radiology

 

Reference

Grabherr S., Heinemann A., Vogel H., et al, “Postmortem CT Angiography Compared with Autopsy: A Forensic Multicenter Study.” Radiology, May 1, 2018. https://doi.org/10.1148/radiol.2018170559

 

Related Content

SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
Siemens Healthineers Announces First U.S. Install of Somatom go.Top CT
News | Computed Tomography (CT) | September 17, 2018
September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare
SmartCurve technology, a revolutionary breast imaging technology designed specifically for the curvature of the female breast to provide every woman with a more comfortable and accurate mammogram.
News | Mammography | September 14, 2018
Solis Mammography declared September Breast Wellness Month a
At RSNA 2018, radiology professionals will discover intelligent radiography powered by MUSICA, at Agfa's booth.

At RSNA 2018, radiology professionals will discover intelligent radiography powered by MUSICA, at Agfa's booth.

News | Digital Radiography (DR) | September 13, 2018
At RSNA 2018, radiology professionals will discover intelligent
Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | September 12, 2018
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore co
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Whitepapers | Radiation Dose Management | September 10, 2018
It’s crucial for medical professionals to understand the radiation risk/ benefit balance of diagnostic imaging system
The CT scanner might not come with protocols that are adequate for each hospital situation, so at Phoenix Children’s Hospital they designed their own protocols, said Dianna Bardo, M.D., director of body MR and co-director of the 3D Innovation Lab at Phoenix Children’s.

The CT scanner might not come with protocols that are adequate for each hospital situation, so at Phoenix Children’s Hospital they designed their own protocols, said Dianna Bardo, M.D., director of body MR and co-director of the 3D Innovation Lab at Phoenix Children’s.

Sponsored Content | Case Study | Radiation Dose Management | September 07, 2018
Radiation dose management is central to child patient safety. Medical imaging plays an increasing role in the accurate...
Overlay Init